ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "pregnancy"

  • Abstract Number: 1295 • 2017 ACR/ARHP Annual Meeting

    Pregnancy Outcome in Patients with SLE Compared to Patients with Other Inflammatory Rheumatic Diseases: Real World Data from a Prospective Pregnancy Register

    Rebecca Fischer-Betz1, Christina Bungartz2, Matthias Schneider1, Jutta Richter1, Anja Weiss2, Angela Zink3 and Anja Strangfeld4, 1Policlinic for Rheumatology & Hiller Research Centre for Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany, 2German Rheumatism Research Center, Berlin, Germany, 3Epidemiology Unit / Rheumatology and Clinical Immunology, German Rheumatism Research Centre (DRFZ) / Charité University Hospital, Berlin, Germany, 4Epidemiology, German Rheumatism Research Center, Berlin, Germany

    Background/Purpose: SLE pregnancies are complicated due to risk for maternal disease exacerbation and potential for fetal and neonatal complications. With careful pre-pregnancy counseling and monitoring…
  • Abstract Number: 1299 • 2017 ACR/ARHP Annual Meeting

    Patient-Reported Disease Activity and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus and Rheumatoid Arthritis

    Nathaniel Harris1, Amanda M. Eudy2 and Megan E. B. Clowse2, 1Duke University School of Medicine, Durham, NC, 2Division of Rheumatology, Department of Medicine, Duke University Medical Center, Durham, NC

    Background/Purpose: Patient-reported measures of disease activity may provide useful adjuncts to physician-reported measures in identifying pregnancies at greater risk for adverse pregnancy outcomes. Little is…
  • Abstract Number: 1309 • 2017 ACR/ARHP Annual Meeting

    Characteristics and Outcomes of Prospectively Reported Pregnancies Exposed to Certolizumab Pegol from a Safety Database

    Megan E. B. Clowse1, Angela E. Scheuerle2, Christina D Chambers3, Anita Afzali4, Alexa Kimball5, John J. Cush6, Maureen Cooney7, Laura Shaughnessy7, Mark Vanderkelen8 and Frauke Förger9, 1Division of Rheumatology, Department of Medicine, Duke University Medical Center, Durham, NC, 2UT Southwestern Medical Center, Dallas, TX, 3UC San Diego School of Medicine, San Diego, CA, 4University of Washington Harborview Medical Center, Seattle, WA, 5Beth Israel Deaconess Medical Center, Boston, MA, 6Baylor Scott & White Research Institute, Dallas, TX, 7UCB Pharma, Raleigh, NC, 8UCB Pharma, Braine-l’Alleud, Belgium, 9Inselspital, University of Bern, Bern, Switzerland

    Background/Purpose: Anti-tumor necrosis factor medications (anti-TNFs) are effective in controlling chronic inflammatory diseases, but information about their use and safety in pregnancy is limited. Consequently,…
  • Abstract Number: 1812 • 2017 ACR/ARHP Annual Meeting

    Preeclampsia and Incident Cardiovascular Disease in SLE Pregnancy

    Julia F Simard1, Marios Rossides2, Elizabeth V. Arkema3, Elisabet Svenungsson4, Anna-Karin Wikstrom5, Murray Mittleman6 and Jane E. Salmon7, 1Division of Epidemiology, Health Research and Policy Department, Stanford School of Medicine, Stanford, CA, 2Medicine Solna, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden, 3Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 4Department of Medicine Solna, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden, 5Clinical Epidemiology Unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden, 6Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, 7Medicine/Rheumatology, Hospital of Special Surgery, New York, NY

    Background/Purpose: Pre-pregnancy cardiovascular health has been associated with preeclampsia during pregnancy, as well as future cardiovascular disease (CVD). Preeclampsia is related to endothelial dysfunction, hypertension,…
  • Abstract Number: 1957 • 2017 ACR/ARHP Annual Meeting

    Impact of Maternal Systemic Autoimmune Rheumatic Diseases on Neonatal Outcomes: A Population-Level Analysis

    Stephanie Keeling1, Anamaria Savu2 and Padmaja Kaul3, 1Department of Medicine, University of Alberta, Division of Rheumatology, Edmonton, AB, Canada, 2Canadian Vigour Center, Edmonton, AB, Canada, 3Cardiology, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: The impact of systemic autoimmune rheumatic diseases (SARDS) on peripartum outcomes is not well described at a population level despite the potential for active…
  • Abstract Number: 2738 • 2016 ACR/ARHP Annual Meeting

    The Effect of Pregnancy on Disease Activity Outcomes in Psoriatic Arthritis Patients

    Mark Berman1, Daphna Paran1, Yonatan Wolman1 and Ori Elkayam2, 1Rheumatology, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 2Rheumatology, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    Background/Purpose : Psoriatic arthritis(PsA) often affects patients at a childbearing age. The relationship between pregnancy and PsA, in terms of pregnancy outcomes and its effect on…
  • Abstract Number: 1533 • 2016 ACR/ARHP Annual Meeting

    Pregnancy Outcomes in Women with Rheumatoid Arthritis : A Systematic Review and Meta-Analyses

    Anne-Lise Gaillard1, Thomas Barnetche2 and Thierry Schaeverbeke3, 1Rhumatologie, CHU Bordeaux Pellegrin, Bordeaux, France, 2Rheumatology Department, Pellegrin University Hospital, BORDEAUX, France, 3Rheumatology Department, Bordeaux Hospital, Bordeaux, France

    Background/Purpose: Actually better control of rheumatoid arthritis (RA) activity leads to new interrogations and daily questions about pregnancy. Only few studies have studied pregnancy outcomes…
  • Abstract Number: 2045 • 2016 ACR/ARHP Annual Meeting

    Early Preeclampsia Risk in Lupus Pregnancy: A Swedish Population-Based Register Investigation

    Julia F Simard1,2, Elizabeth V. Arkema3, Cathina Nguyen4, Elisabet Svenungsson5, Anna-Karin Wikstrom6,7, Kristin Palmsten8 and Jane E. Salmon9, 1Division of Epidemiology, Health Research and Policy Department, and Division of Immunology & Rheumatology, Department of Medicine, Stanford School of Medicine, Stanford, CA, 2Clinical Epidemiology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 3Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 4Health Research & Policy, Stanford School of Medicine, Stanford, CA, 5Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 6Department of Clinical Sciences, Danderyd Hospital, Stockholm, Sweden, 7Clinical Epidemiology Unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden, 8Department of Pediatrics, University of California, San Diego, La Jolla, CA, 9Division of Rheumatology, Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose:  Early preeclampsia is a serious pregnancy complication characterized by abnormal placentation and diffuse maternal endothelial cell dysfunction, and requires emergent delivery which may be…
  • Abstract Number: 2437 • 2016 ACR/ARHP Annual Meeting

    Causes of Cesarean Section and Labor Induction in Systemic Lupus Erythematosus and Rheumatoid Arthritis Pregnancies

    Amanda M. Eudy, Laura Neil and Megan E. B. Clowse, Rheumatology, Duke University Medical Center, Durham, NC

    Background/Purpose: Women with SLE and RA have an increased risk of delivering a preterm infant. However, the causes of these preterm births remain unknown. Some…
  • Abstract Number: 2439 • 2016 ACR/ARHP Annual Meeting

    Effect of Pregnancy Counseling on the Outcome of Pregnancies in Women with Systemic Lupus Erythematosus: A Prospective Observational Study

    Rebecca Fischer-Betz1, Lisa Kueppers2, Ralph Brinks2, Oliver Sander3, Christof Specker4 and Matthias Schneider3, 1Policlinic of Rheumatology and Hiller Research Unit Rheumatology, Heinrich-Heine University, Duesseldorf, Duesseldorf, Germany, 2Department of Rheumatology&Hiller Research Unit, Heinrich-Heine-University, Duesseldorf, Germany, 3Department of Rheumatology & Hiller Research Unit, Heinrich-Heine-University, Duesseldorf, Germany, 4Rheumatology and Clinical Immunology, Kliniken Essen Sued, Essen, Germany

    Background/Purpose: Pregnancies in women with systemic lupus erythematosus (SLE) are associated with increased frequencies of adverse pregnancy outcomes (APOs). Preconception counseling including risk stratification and…
  • Abstract Number: 2440 • 2016 ACR/ARHP Annual Meeting

    First Results from the Prospective German Pregnancy Register

    Rebecca Fischer-Betz1, Christina Bungartz2, Jutta Richter1, Angela Zink3, Matthias Schneider1, Anja Weiss2, Joachim Listing4 and Anja Strangfeld5, 1Department of Rheumatology & Hiller Research Unit, Heinrich-Heine-University, Duesseldorf, Germany, 2German Rheumatism Research Centre, Berlin, Germany, 3Epidemiology Unit, German Rheumatism Research Center and Charité University Medicine, Berlin, Germany, 4German Rheumatism Research Center, Berlin, Germany, 5Epidemiology, German Rheumatism Research Center, Berlin, Germany

    Background/Purpose: There is limited evidence on the safety of treatment during pregnancy and lactation. With the increasing number of new therapeutic options for inflammatory rheumatic…
  • Abstract Number: 2442 • 2016 ACR/ARHP Annual Meeting

    Use of Nonsteroidal Anti-Inflammatory Drugs in Pregnant Women with Inflammatory Arthritis

    Neda Amiri1, Gretchen Bandoli2, Diana L Johnson2 and Christina D. Chambers2, 1Division of Rheumatology, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada, 2Pediatrics, University of California, San Diego, La Jolla, CA

    Use of Nonsteroidal Anti-inflammatory Drugs in Pregnant Women with Inflammatory Arthritis Background/Purpose: Nonsteroidal anti-inflammatory drugs (NSAIDs) are generally contraindicated in the third trimester of pregnancy…
  • Abstract Number: 2443 • 2016 ACR/ARHP Annual Meeting

    Pregnancy Comorbidities and Outcomes in Psoriasis and Psoriatic Arthritis: A Prospective Cohort Study

    Neda Amiri1, Gretchen Bandoli2 and Christina Chambers2, 1Division of Rheumatology, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada, 2Pediatrics, University of California, San Diego, La Jolla, CA

    Pregnancy Comorbidities and Outcomes in Psoriasis and Psoriatic Arthritis: A Prospective Cohort Study Background/Purpose: While there is some evidence that women with psoriasis (Pso) and…
  • Abstract Number: 2536 • 2015 ACR/ARHP Annual Meeting

    The Role of Race/Ethnicity and SES in Adverse Pregnancy Outcome in SLE and Apl

    Sancia Ferguson1, Elianna Kaplowitz2, Laura Trupin3, Edward H. Yelin4, Patricia P. Katz3,5 and Jane E. Salmon6, 1Medicine/Rheumatology, University of California - San Francisco, San Francisco, CA, 2Hospital for Special Surgery, New York, NY, 3Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, 4Medicine/Rheumatology, UC San Francisco, San Francisco, CA, 5Arthritis Research Group, University of California San Francisco, San Francisco, CA, 6Division of Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY

    Background/Purpose: Women with Systemic Lupus Erythematosus (SLE) and Anti-Phospholipid Antibodies (aPL) have pregnancies with higher rates of preterm labor, preeclampsia, and fetal loss than healthy…
  • Abstract Number: 2528 • 2015 ACR/ARHP Annual Meeting

    Utilization of Immune-Suppressive Medications during Pregnancy Among Women with Inflammatory Arthritis and Other Autoimmune Diseases

    Jie Zhang1,2, Jeffrey R. Curtis3, Fenglong Xie4, Melissa L. Mannion5, James D. Lewis6,7, Megan E. B. Clowse8, Kenneth G. Saag3, Steven Bethard9, Jospeh Biggio9, Gerald McGwin9 and Timothy Beukelman10, 1Epidemilogy, University of Alabama at Birmingham, Birmingham, AL, 2Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3University of Alabama at Birmingham, Birmingham, AL, 4Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, 5Pediatrics, University of Alabama at Birmingham, Birmingham, AL, 6University of Pennsylvania, Philadelphia, PA, 7Medicine, University of Pennsylvania, Philadelphia, PA, 8Clinical Rheumatologist, Duke University Medical Center, Durham, NC, 9UAB, Birmingham, AL, 10Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: To examine difference in the prevalence of immunosuppressive medication use during pregnancy by type of autoimmune disease and by insurance (Medicaid versus commercial) in…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences